Task: Answer the multiple choice question.
Query: Which drug exhibits a -8.540\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. Brc1ccc(-c2csc(/N=C/N3CCOCC3)n2)cc1
b. COc1ccc(CCn2ccc(O)c(Cc3ccc(Cl)cc3Cl)c2=O)cc1OC
c. CCN(c1ccc(NS(=O)(=O)c2cc(Cl)ccc2Cl)cc1)C(C)C
d. CC(C)CCNC(=O)C1CC(=O)N(C2CCCC2)C1
Answer: a. Brc1ccc(-c2csc(/N=C/N3CCOCC3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Brc1ccc(-c2csc(/N=C/N3CCOCC3)n2)cc1
Brc1ccc(-c2csc(/N=C/N3CCOCC3)n2)cc1
(E)-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-1-morpholin-4-ylmethanimine